Shilpa Gupta: Honored and humbled to present the PROs from EV-302 of EV-P vs plat in mUC ASCO

Shilpa Gupta shared a post on X:

“Honored and humbled to present the PROs from EV-302 of EV-P vs plat in mUC ASCO Mon, Jun 3, 8 AM session co-chaired by Maite Bourlon, Suzanne Cole.”

Source: Shilpa Gupta/X

Dr. Shilpa Gupta is the Director of Genitourinary Medical Oncology at Taussig Cancer Institute and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic. Dr. Gupta’s extensive research focuses on novel drug development and biomarkers of response/resistance in bladder cancer, contributing to numerous published works and leadership roles in clinical trials.